Avelumab/Gemcitabine in Sarcomatoid RCC

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2018
To determine the feasibility and safety of avelumab and gemcitabine combination therapy in patients with metastatic sRCC.
Epistemonikos ID: 40bf435e7e2b188ec301c4ac5d7fb5603a84350a
First added on: May 21, 2024